FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095888910> ?p ?o ?g. }

• W3095888910 endingPage "144" @default.
• W3095888910 startingPage "131" @default.
• W3095888910 abstract "Guidelines endorse the use of chemoprevention for breast cancer risk reduction. This study examined the barriers and facilitators to chemoprevention use for Australian women at increased risk of breast cancer, and their clinicians. Surveys, based on the Theoretical Domains Framework, were mailed to 1,113 women at ≥16% lifetime risk of breast cancer who were enrolled in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer cohort study (kConFab), and their 524 treating clinicians. Seven hundred twenty-five women (65%) and 221 (42%) clinicians responded. Only 10 (1.4%) kConFab women had ever taken chemoprevention. Three hundred seventy-eight (52%) kConFab women, two (3%) breast surgeons, and 51 (35%) family physicians were not aware of chemoprevention. For women, the strongest barriers to chemoprevention were side effects (31%) and inadequate information (23%), which operate in the Theoretical Domains Framework domains of beliefs about consequences and knowledge, respectively. Strongest facilitators related to tamoxifen's long-term efficacy (35%, knowledge, beliefs about consequences, and goals domains), staying healthy for family (13%, social role and goals domains), and abnormal breast biopsy (13%, environmental context domain). The strongest barrier for family physicians was insufficient knowledge (45%, knowledge domain) and for breast surgeons was medication side effects (40%, beliefs about consequences domain). The strongest facilitators for both clinician groups related to clear guidelines, strong family history, and better tools to select patients (environmental context and resources domain). Clinician knowledge and resources, and beliefs about the side-effect consequences of chemoprevention, are key domains that could be targeted to potentially enhance uptake. PREVENTION RELEVANCE: Despite its efficacy in reducing breast cancer incidence, chemoprevention is underutilised. This survey study of Australian women and their clinicians used behavioural change theory to identify modifiable barriers to chemoprevention uptake, and to suggest interventions such as policy change, educational resources and public campaigns, that may increase awareness and use.See related Spotlight by Vogel, p. 1." @default.
• W3095888910 created "2020-11-09" @default.
• W3095888910 creator A5002129123 @default.
• W3095888910 creator A5010740005 @default.
• W3095888910 creator A5014440215 @default.
• W3095888910 creator A5021894535 @default.
• W3095888910 creator A5023667273 @default.
• W3095888910 creator A5030816509 @default.
• W3095888910 creator A5040933938 @default.
• W3095888910 creator A5047732476 @default.
• W3095888910 creator A5049054941 @default.
• W3095888910 creator A5050340548 @default.
• W3095888910 creator A5060453465 @default.
• W3095888910 creator A5064150548 @default.
• W3095888910 creator A5069713035 @default.
• W3095888910 date "2021-01-01" @default.
• W3095888910 modified "2023-10-14" @default.
• W3095888910 title "Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians" @default.
• W3095888910 cites W1590666178 @default.
• W3095888910 cites W1975636869 @default.
• W3095888910 cites W1980278232 @default.
• W3095888910 cites W1982581191 @default.
• W3095888910 cites W2006202627 @default.
• W3095888910 cites W2031163560 @default.
• W3095888910 cites W2044734659 @default.
• W3095888910 cites W2045827655 @default.
• W3095888910 cites W2049869682 @default.
• W3095888910 cites W2054993166 @default.
• W3095888910 cites W2057750876 @default.
• W3095888910 cites W2067962376 @default.
• W3095888910 cites W2068199727 @default.
• W3095888910 cites W2077109464 @default.
• W3095888910 cites W2095123988 @default.
• W3095888910 cites W2099535971 @default.
• W3095888910 cites W2107859602 @default.
• W3095888910 cites W2133966082 @default.
• W3095888910 cites W2136608905 @default.
• W3095888910 cites W2139434007 @default.
• W3095888910 cites W2161387798 @default.
• W3095888910 cites W2169449395 @default.
• W3095888910 cites W2195518879 @default.
• W3095888910 cites W2285718864 @default.
• W3095888910 cites W2330425005 @default.
• W3095888910 cites W2517360465 @default.
• W3095888910 cites W2589059073 @default.
• W3095888910 cites W2625891324 @default.
• W3095888910 cites W2754613467 @default.
• W3095888910 cites W2765618874 @default.
• W3095888910 cites W2803033422 @default.
• W3095888910 cites W2899746231 @default.
• W3095888910 cites W2902630415 @default.
• W3095888910 cites W2938233323 @default.
• W3095888910 cites W2971583637 @default.
• W3095888910 cites W2974363867 @default.
• W3095888910 cites W2981672817 @default.
• W3095888910 cites W2994434911 @default.
• W3095888910 cites W2996341812 @default.
• W3095888910 cites W2996735769 @default.
• W3095888910 cites W3035321842 @default.
• W3095888910 doi "https://doi.org/10.1158/1940-6207.capr-20-0369" @default.
• W3095888910 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33115784" @default.
• W3095888910 hasPublicationYear "2021" @default.
• W3095888910 type Work @default.
• W3095888910 sameAs 3095888910 @default.
• W3095888910 citedByCount "4" @default.
• W3095888910 countsByYear W30958889102021 @default.
• W3095888910 countsByYear W30958889102023 @default.
• W3095888910 crossrefType "journal-article" @default.
• W3095888910 hasAuthorship W3095888910A5002129123 @default.
• W3095888910 hasAuthorship W3095888910A5010740005 @default.
• W3095888910 hasAuthorship W3095888910A5014440215 @default.
• W3095888910 hasAuthorship W3095888910A5021894535 @default.
• W3095888910 hasAuthorship W3095888910A5023667273 @default.
• W3095888910 hasAuthorship W3095888910A5030816509 @default.
• W3095888910 hasAuthorship W3095888910A5040933938 @default.
• W3095888910 hasAuthorship W3095888910A5047732476 @default.
• W3095888910 hasAuthorship W3095888910A5049054941 @default.
• W3095888910 hasAuthorship W3095888910A5050340548 @default.
• W3095888910 hasAuthorship W3095888910A5060453465 @default.
• W3095888910 hasAuthorship W3095888910A5064150548 @default.
• W3095888910 hasAuthorship W3095888910A5069713035 @default.
• W3095888910 hasBestOaLocation W30958889101 @default.
• W3095888910 hasConcept C121608353 @default.
• W3095888910 hasConcept C126322002 @default.
• W3095888910 hasConcept C151730666 @default.
• W3095888910 hasConcept C2777176818 @default.
• W3095888910 hasConcept C2779343474 @default.
• W3095888910 hasConcept C2781179581 @default.
• W3095888910 hasConcept C29456083 @default.
• W3095888910 hasConcept C512399662 @default.
• W3095888910 hasConcept C530470458 @default.
• W3095888910 hasConcept C71924100 @default.
• W3095888910 hasConcept C72563966 @default.
• W3095888910 hasConcept C86803240 @default.
• W3095888910 hasConceptScore W3095888910C121608353 @default.
• W3095888910 hasConceptScore W3095888910C126322002 @default.
• W3095888910 hasConceptScore W3095888910C151730666 @default.
• W3095888910 hasConceptScore W3095888910C2777176818 @default.

• next